Regarding the toxicity, the SqCC patients developed hyperglycemia (23.3%) and fatigue (6.7% each), whereas the non-squamous cancer subjects developed increased ALT (15.2%), hyperglycemia (12.1%), and rash (6.1%). The gene discussed is GPT; the disease is Hyperglycemia.